ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01253460
Brief Title: Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)

First Submitted : December 1, 2010
First Submitted that Met QC Criteria : December 1, 2010
First Posted : December 3, 2010 (Estimate)

Last Update Submitted that Met QC Criteria : April 5, 2018
Last Update Posted : April 9, 2018